Lantern Pharma Inc. (LTRN)
Acadia Pharmaceuticals (ACAD)
Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Merit Medical Systems Inc (MMSI)
Merit Medical Systems To Announce Second Quarter 2025 Results On July 30, 2025
Agenus Inc. (AGEN)
Immunome Inc (IMNM)
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Fate Therapeutics Inc (FATE)
ProKidney Corp (PROK)
New Form 8-K12B - PROKIDNEY CORP. Filed: 2025-07-03 AccNo: 0001140361-25-024839 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.03: Material Modifications to Rights of Security Holders Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers …
FibroBiologics, Inc. (FBLG)
Scorpius Holdings Inc. (SCPX)
New Form 8-K - Scorpius Holdings, Inc. Filed: 2025-07-03 AccNo: 0001079973-25-001106 Size: 236 KB Item 1.01: Entry into a Material Definitive Agreement Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant Item 3.02: Unregistered Sales of Equity Securities Item 9.01: …
Fate Therapeutics Inc (FATE)
Agios Pharmaceuticals Inc (AGIO)
Jasper Therapeutics Inc. (JSPRW)
Neurogene Inc. (NGNE)
Neurogene Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)